A single intranasal pretreatment with 100 IU of murine IFNα given 8-48 hours before viral challenge reduced lung viral titers and protected BALB/c mice against lethal H5N1 or pandemic H1N1 viral infections. The gene discussed is IFNA1; the disease is viral infectious disease.